CD8A and Zika virus infectious disease: Anti-ZIKV vaccines are therefore focused on generating protective CD8+ and CD4+ T cells in order to control ZIKV infection and promote virus clearance, thereby avoiding harmful ADE effects with potential reinfection events by ZIKV or other flaviviruses [121,128,373,374,375].